Williamstown Dispensary is First of Five Planned Locations to Serve State’s Growing Medical Cannabis Program; Next Three Locations Expected to Open this Spring
NEW YORK--(BUSINESS WIRE)-- Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and providers of cannabis products in the U.S., announced Cannabist Williamstown, its first dispensary in West Virginia and 24th Cannabist nationwide, opened today. Cannabist Williamstown, located at 76 Thunder Road in Williamstown, is the first of five dispensaries that Columbia Care will open in the state this year.
“The level of demand and excitement for high quality cannabis and best-in-class service in West Virginia is promising for such a nascent medical market. We’re here to be a leader and a resource for current and future patients, as we introduce them to the power of this incredible plant,” said Jesse Channon, Chief Growth Officer of Columbia Care. “As the medical cannabis program continues to expand, we look forward to also serving as a wholesale partner to ensure that patient needs are met across the state with a variety of high quality options. We’re thankful to the local community for welcoming Cannabist and to the Department of Health and Human Resources for their continued support.”
Columbia Care began cultivation operations at its 40,000-square-foot facility in West Virginia in July 2021. The Company holds five dispensary licenses to serve the growing number of registered medical cannabis patients across the state. Cannabist Williamstown staff held a series of educational events throughout the month of December. These events helped patients better understand the state’s medical cannabis program, including providing information on how to obtain a medical cannabis patient card and which products will be available, as well as connected prospective patients with registered medical practitioners.
Cannabist Williamstown will offer Columbia Care’s Seed & Strain brand in multiple forms, including whole flower and vape carts. The Company’s other portfolio brands such as Triple Seven and Classix will be introduced in the coming months for patients and wholesale partners. Patients will also be able to use Columbia Care’s proprietary cannabis discovery tool, Forage, both in-store and online to help find strains and products to fit their needs.
The Company is expecting to open three more Cannabist dispensaries in the spring with locations in Beckley, Morgantown and St. Albans, as well as a fifth location to follow later in 2022.
For more information on the Company’s West Virginia locations, visit www.gocannabist.com/wv.
About Columbia Care
Columbia Care is one of the largest and most experienced cultivators, manufacturers and providers of cannabis products and related services, with licenses in 18 U.S. jurisdictions and the EU. Columbia Care operates 131 facilities including 99 dispensaries and 32 cultivation and manufacturing facilities, including those under development. Columbia Care is one of the original multi-state providers of medical cannabis in the U.S. and now delivers industry-leading products and services to both the medical and adult-use markets. In 2021, the company launched Cannabist, its new retail brand, creating a national dispensary network that leverages proprietary technology platforms. The company offers products spanning flower, edibles, oils and tablets, and manufactures popular brands including Seed & Strain, Triple Seven, gLeaf, Classix, Press, Amber and Platinum Label CBD. For more information on Columbia Care, please visit www.col-care.com.
Caution Concerning Forward-Looking Statements
This press release contains certain statements that constitute forward-looking information within the meaning of applicable securities laws and reflect the Company’s current expectations regarding future events. The Company has made assumptions with regard to its ability to execute on brand and product initiatives, which although considered reasonable by the Company, may prove to be incorrect and are subject to known and unknown risks and uncertainties that may cause actual results, performance or achievements of the Company to be materially different from those expressed or implied by any forward-looking information. Securityholders should review the risk factors discussed under “Risk Factors” in Columbia Care’s Annual Information Form dated March 31, 2021, filed with the applicable Canadian securities regulatory authorities on SEDAR at www.sedar.com and described from time to time in documents filed by the Company with Canadian securities regulatory authorities.
Lee Ann Evans
Source: Columbia Care Inc.
Released February 3, 2022